TASIGNA LAWSUIT

TASIGNA LAWSUIT ​First approved in 2007, Tasigna (nilotinib), is a prescription medication used to treat chronic myeloid leukaemia (CML). Tasigna is part of a class of drugs known as tyrosine kinase inhibitors (TKIs). Other TKI drugs include Gleevec (imatinib), also made by Novartis, and Sprycel (dasatinib), made by Bristol-Myers Squibb. ​ These drugs help treat leukemia by blocking the protein tyrosine kinases—a protein that stimulates the growth of cancer cells. In blocking this protein, TKI drugs like Tasigna help stop leukemia from spreading. Tasigna is prescribed as a twice daily drug and is taken orally in capsule form. Injured patients and their families are now filing lawsuits against Tasigna manufacturer Novartis, on the grounds that the company failed to warn of the drug’s cardiovascular risks. Studies have allegedly linked the drug to serious cardiovascular side effects like Long QT syndrome, a condition involving irregular heartbeats, and atherosclerosis, a disease that causes plaque to build up in the arteries.​​ If you or a loved one took Tasigna and suffered heart or circulation problems (including complications like blocked arteries, heart attacks, or strokes), you could be eligible for a Tasigna Lawsuit. If you suffered Tasigna side effects, including Tasigha cardiovascular side effects, call Tasigna lawyer Timothy L. Miles today for a free case evaluation and see if you qualify for a Tasigna lawsuit. Follow us: https://www.facebook.com/timmileslaw https://twitter.com/TimMile83043830 https://www.linkedin.com/company/the-law-offices-of-timothy-l-miles https://www.youtube.com/channel/UCbEh7RkQ94C6KVlZGubIYmQ https://www.pinterest.com/tmiles676767/ https://www.instagram.com/10k_law/1

from
https://www.youtube.com/watch?v=FGDpHb8l4A8